A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)
Public ClinicalTrials.gov record NCT05194839. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Dose Ranging Phase 2 Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects With Palmoplantar Pustulosis
Study identification
- NCT ID
- NCT05194839
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Aristea Therapeutics, Inc.
- Industry
- Enrollment
- 79 participants
Conditions and interventions
Conditions
Interventions
- RIST4721 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 74 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 4, 2022
- Primary completion
- Feb 12, 2023
- Completion
- Mar 5, 2023
- Last update posted
- Jun 28, 2023
2022 – 2023
United States locations
- U.S. sites
- 19
- U.S. states
- 15
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Total Skin & Beauty Dermatology Center, PC | Birmingham | Alabama | 35205 | — |
| Dermatology Trial Associates | Bryant | Arkansas | 72022 | — |
| Cosmetic Laser Dermatology | San Diego | California | 92121 | — |
| Clinical Science Institute | Santa Monica | California | 90404 | — |
| Driven Research LLC | Coral Gables | Florida | 33134 | — |
| Encore Medical Research, LLC | Hollywood | Florida | 33021 | — |
| Tory Sullivan, MD PA | North Miami Beach | Florida | 33162 | — |
| Advanced Medical Research PC | Sandy Springs | Georgia | 30328 | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46250 | — |
| DS Research | Louisville | Kentucky | 40241 | — |
| Great Lakes Research Group, Inc. | Bay City | Michigan | 48706 | — |
| Washington University School of Medicine-Dermatology | St Louis | Missouri | 63108 | — |
| Skin Specialists, PC (Schlessinger MD) | Omaha | Nebraska | 68144 | — |
| ALLCUTIS Research, LLC. | Portsmouth | New Hampshire | 03801 | — |
| Aventiv Research Inc. | Dublin | Ohio | 43016 | — |
| Apex Clinical Research Center | Mayfield Heights | Ohio | 44124 | — |
| Central Sooner Research | Norman | Oklahoma | 73071 | — |
| UPMC Department of Dermatology | Pittsburgh | Pennsylvania | 15212 | — |
| Dermatology Clinical Research Center of San Antonio | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05194839, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 28, 2023 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05194839 live on ClinicalTrials.gov.